MARKET

LGND

LGND

Ligand Pharma
NASDAQ
190.44
-1.25
-0.65%
After Hours: 190.44 0 0.00% 16:10 02/06 EST
OPEN
194.61
PREV CLOSE
191.69
HIGH
197.00
LOW
189.17
VOLUME
272.77K
TURNOVER
--
52 WEEK HIGH
212.49
52 WEEK LOW
93.58
MARKET CAP
3.75B
P/E (TTM)
91.65
1D
5D
1M
3M
1Y
5Y
1D
Analysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Qiagen (QGEN) and Ligand Pharma (LGND)
TipRanks · 2d ago
MedCap AB erzielt im Gesamtjahr 2025 einen Umsatz von 2.108 Mio. SEK und eine EBITA-Marge von 18 Prozent
Reuters · 2d ago
Ligand Pharmaceuticals Director John W. Kozarich Reports Disposal of Common Shares
Reuters · 4d ago
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AbbVie (ABBV) and Bio-Techne (TECH)
TipRanks · 4d ago
Ligand Pharmaceuticals Executives to Participate in Oppenheimer Healthcare Life Sciences Conference
Reuters · 4d ago
Ligand Pharmaceuticals nimmt an der Oppenheimer Healthcare Life Sciences Conference teil
Reuters · 4d ago
Agilent Technologies kooperiert mit Virscidian zur Integration von OpenLab CDS und Analytical Studio
Reuters · 5d ago
Atlas Copco übernimmt deutschen Filterspezialisten Zind Verfahrenstechnik
Reuters · 5d ago
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.